DexCom (DXCM) stock has been in focus after Investor Day communications that many fund managers say improved sentiment, ...
Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...
Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be ...
Shares of DexCom Inc. DXCM shed 1.40% to $73.02 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.81% to 7,543.64 and the Dow ...
If you are wondering whether DexCom stock still offers value after a choppy few years, this article walks through what the ...
Shares of DexCom Inc. DXCM advanced 3.47% to $71.25 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX remaining mostly unchanged at 7, ...
DXCM's redesigned Stelo app is set for a July U.S. rollout, with international expansion and pediatric clearance broadening ...
In a report released on July 6, Joanne Wuensch from Citi reiterated a Buy rating on Dexcom, with a price target of $84.00. The company’s shares closed yesterday at $72.38. 55% O ...
AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...
The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...
Zacks Investment Research on MSN
Here's why DexCom (DXCM) is a strong growth stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
FDA's crackdown on online ketamine retailers, unprecedented health care premium hikes, and more health news from Morning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results